The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Real-Time PCR Technology for Cancer Diagnostics
Abstract
Background: Advances in the biological sciences and technology are providing molecular targets for diagnosing and treating cancer. Current classifications in surgical pathology for staging malignancies are based primarily on anatomic features (e.g., tumor-node-metastasis) and histopathology (e.g., grade). Microarrays together with clustering algorithms are revealing a molecular diversity among cancers that promises to form a new taxonomy with prognostic and, more importantly, therapeutic significance. The challenge for pathology will be the development and implementation of these molecular classifications for routine clinical practice. Approach: This article discusses the benefits, challenges, and possibilities for solid-tumor profiling in the clinical laboratory with an emphasis on DNA-based PCR techniques. Content: Molecular markers can be used to provide accurate prognosis and to predict response, resistance, or toxicity to therapy. The diversity of genomic alterations involved in malignancy necessitates a variety of assays for complete tumor profiling. Some new molecular classifications of tumors are based on gene expression, requiring a paradigm shift in specimen processing to preserve the integrity of RNA for analysis. More stable markers (i.e., DNA and protein) are readily handled in the clinical laboratory. Quantitative real-time PCR can determine gene duplications or deletions. Furthermore, melting curve analysis immediately after PCR can identify small mutations, down to single base changes. These techniques are becoming easier and faster and can be multiplexed. Real-time PCR methods are a favorable option for the analysis of cancer markers. Summary: There is a need to translate recent discoveries in oncology research into clinical practice. This requires objective, robust, and cost-effective molecular techniques for clinical trials and, eventually, routine use. Real-time PCR has attractive features for tumor profiling in the clinical laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
Shao, Z. M., Wu, J., Shen, Z., & Nguyen, M. (2001) · PubMed · Cited by 64
RetractedMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Spellman, P. T., Sherlock, G., Zhang, M. Q., Iyer, V. R., Anders, K., Eisen, M. B., Brown, P. O., Botstein, D., & Futcher, B. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3273 · Cited by 4,722
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,318
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Genome-wide analysis of DNA copy-number changes using cDNA microarrays
Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., & Brown, P. O. (1999) · Nature Genetics · doi:10.1038/12640 · Cited by 1,423
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Diversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,298
Continuous Fluorescence Monitoring of Rapid Cycle DNA Amplification
Wittwer, C. T., Herrmann, M. G., Moss, A. A., & Rasmussen, R. P. (2013) · BioTechniques · doi:10.2144/000114043 · Cited by 1,274
Self-citationContinuous Fluorescence Monitoring of Rapid Cycle DNA Amplification
Wittwer, C. T., Herrmann, M. G., Moss, A. A., & Rasmussen, R. P. (1997) · BioTechniques · doi:10.2144/97221bi01 · Cited by 1,143
Self-citationRosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1639 · Cited by 1,097
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Ross, J. S., & Fletcher, J. A. (1998) · STEM CELLS · doi:10.1002/stem.160413 · Cited by 985
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Pauletti, G., Dandekar, S., Rong, H., Ramos, L., Peng, H., Seshadri, R., & Slamon, D. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3651 · Cited by 670
Rapid Cycle Real-Time PCR: Methods and Applications
Wittwer, C. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_1 · Cited by 630
Self-citationMoulder, S. L., Yakes, F. M., Muthuswamy, S. K., Bianco, R., Simpson, J. F., & Arteaga, C. L. (2001) · PubMed · Cited by 597
Paik, S., Hazan, R., Fisher, E. R., Sass, R. E., Fisher, B., Redmond, C., Schlessinger, J., Lippman, M. E., & King, C. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.1.103 · Cited by 594
Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
Schlecht, N. F. (2001) · JAMA · doi:10.1001/jama.286.24.3106 · Cited by 590
Baas, I. O., Mulder, J. R., Offerhaus, G. J. A., Vogelstein, B., & Hamilton, S. R. (1994) · The Journal of Pathology · doi:10.1002/path.1711720104 · Cited by 505
Bergh, J., Norberg, T., Sjögren, S., Lindgren, A., & Holmberg, L. (1995) · Nature Medicine · doi:10.1038/nm1095-1029 · Cited by 460
Laser-capture microdissection: opening the microscopic frontier to molecular analysis
Simone, N. L., Bonner, R. F., Gillespie, J. W., Emmert-Buck, M. R., & Liotta, L. A. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01489-9 · Cited by 458
Jacobs, T. W., Gown, A. M., Yaziji, H., Barnes, M. J., & Schnitt, S. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.1983 · Cited by 457
Järvinen, T. A. H., Tanner, M., Rantanen, V., Bärlund, M., Borg, Å., Grénman, S., & Isola, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64952-8 · Cited by 387
DNA methylation, chromatin inheritance, and cancer
Rountree, M. R., Bachman, K. E., Herman, J. G., & Baylin, S. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204339 · Cited by 384
Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., & Bergh, J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.173 · Cited by 381
Molecular cytogenetics of primary breast cancer by CGH
Tirkkonen, M., Tanner, M., Karhu, R., Kallioniemi, A., Isola, J., & Kallioniemi, O.-P. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199803)21:3<177::aid-gcc1>3.0.co;2-x · Cited by 372
Kallioniemi, O., Holli, K., Visakorpi, T., Koivula, T., Helin, H. H., & Isola, J. J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490504 · Cited by 346
Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR
Lay, M. J., & Wittwer, C. T. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2262 · Cited by 331
Self-citationGeisler, S. B., Lønning, P. E., Aas, T., Johnsen, H., Fluge, Ø., Haugen, D. F., Lillehaug, J. R., Akslen, L. A., & Børresen‐Dale, A. (2001) · PubMed · Cited by 326
American Joint Committee on Cancer Prognostic Factors Consensus Conference
Yarbro, J. W., Page, D. L., Fielding, L. P., Partridge, E. E., & Murphy, G. P. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2436::aid-cncr35>3.0.co;2-# · Cited by 266
Crockett, A. O., & Wittwer, C. T. (2001) · Analytical Biochemistry · doi:10.1006/abio.2000.4957 · Cited by 238
Self-citationHerbst, R. S., & Langer, C. J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.31525 · Cited by 237
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.325 · Cited by 202
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Berns, E., Foekens, J. A., van Vossen, R., et al. (2000) · PubMed · Cited by 196
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Børresen, A. L., Hovig, E., Smith-Sørensen, B., Malkin, D., Lystad, S., Andersen, T. I., Nesland, J. M., Isselbacher, K. J., & Friend, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8405 · Cited by 190
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen, T. A. H., Tanner, M., Barlund, M. T., Borg, Å., & Isola, J. J. (1999) · PubMed · Cited by 188
Wang, S., Saboorian, M. H., Frenkel, E., Hynan, L., Gokaslan, S. T., & Ashfaq, R. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.5.374 · Cited by 180
Børresen, A., Andersen, T. I., Eyfjörd, J. E., Cornelis, R. S., Thorlacius, S., Borg, Å., Johansson, U., Theillet, C., Scherneck, S., Hartman, S., et al. (1995) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870140113 · Cited by 178
Homogeneous Multiplex Genotyping of Hemochromatosis Mutations with Fluorescent Hybridization Probes
Bernard, P. S., Ajioka, R. S., Kushner, J. P., & Wittwer, C. T. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65650-7 · Cited by 148
Self-citationSoong, R., Robbins, P., Dix, B. R., Grieu, F., Lim, B. H. G., Knowles, S., Williams, K. E., Turbett, G. R., House, A. K., & Iacopetta, B. J. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90282-8 · Cited by 147
Lehmann, U., Glöckner, S. C., Kleeberger, W., von Wasielewski, H. F. R., & Kreipe, H. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65059-6 · Cited by 145
Gonzalez, R., Silva, J. M. R., Sánchez, A., Domínguez, G., Garcia, J. M., Chen, X. Q., Stroun, M., Provencio, M., España, P., Anker, P., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008305412635 · Cited by 100
Emerging Homogeneous DNA-based Technologies in the Clinical Laboratory
Foy, C. A., & Parkes, H. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.990 · Cited by 93
Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast Carcinomas
Gancberg, D., Lespagnard, L., Rouas, G., Paesmans, M., Piccart, M. J., Leo, A. D., Nogaret, J., Hertens, D., Verhest, A. P., & Larsimont, D. (2000) · American Journal of Clinical Pathology · doi:10.1309/0f58-0grx-fk4r-a6va · Cited by 91
Detection of Mitochondrial DNA Mutations by Temporal Temperature Gradient Gel Electrophoresis
Chen, T., Boles, R. G., & Wong, L. C. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1162 · Cited by 90
Bernard, P. S., Pritham, G. H., & Wittwer, C. T. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4217 · Cited by 72
Self-citationAngelis, P. M. D., Stokke, T., Beigi, M., Mjåland, O., & Clausen, O. P. F. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840000275 · Cited by 67
von Ahsen, N., Oellerich, M., & Schütz, E. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.156 · Cited by 63
Wiltshire, R. N., Rasheed, B. K. A., Friedman, H. S., et al. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.164 · Cited by 53
Iacopetta, B. J., Grieu, F., Powell, B. L., et al. (1998) · PubMed · Cited by 53
Watanabe, T., Imoto, I., Kosugi, Y., Ishiwata, I., Inoue, S., Takayama, M., Sato, A., & Inazawa, J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6132 · Cited by 47
Evaluation of the Apo E Genotyping Kit on the LightCycler
Nauck, M., Hoffmann, M. M., Wieland, H., & März, W. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.722 · Cited by 44
Marsh, D. J., Theodosopoulos, G., Howell, V. M., Richardson, A., Benn, D. E., Proos, A., Eng, C., & Robinson, B. G. (2001) · Neoplasia · doi:10.1038/sj.neo.7900154 · Cited by 33
Cited by
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Self-citationThe genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Storhoff, J. J., Lucas, A. D., Garimella, V., Bao, Y. P., & Müller, U. R. (2004) · Nature Biotechnology · doi:10.1038/nbt977 · Cited by 546
Properties of the Reverse Transcription Reaction in mRNA Quantification
Ståhlberg, A., Håkansson, J., Xian, X., Semb, H., & Kubista, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026161 · Cited by 409
Shen, F., Du, W., Kreutz, J. E., Fok, A., & Ismagilov, R. F. (2010) · Lab on a Chip · doi:10.1039/c004521g · Cited by 295
Metadata
- Authors
- Bernard, P. S., & Wittwer, C. T.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-01
- Volume
- 48
- Issue
- 8
- Pages
- 1178-1185
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2100869063
- Cited by
- 273
- References
- 63
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.